The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Durham, M. M.
Right arrow Articles by Larsen, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Durham, M. M.
Right arrow Articles by Larsen, C. P.
The Journal of Immunology, 2000, 165: 1-4.
Copyright © 2000 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Administration of Anti-CD40 Ligand and Donor Bone Marrow Leads to Hemopoietic Chimerism and Donor-Specific Tolerance Without Cytoreductive Conditioning1

Megan M. Durham2, Adam W. Bingaman2, Andrew B. Adams, Jongwon Ha3, Seung-Yeun Waitze, Thomas C. Pearson4 and Christian P. Larsen4

Carlos and Marguerite Mason Transplantation Biology Research Center, Department of Surgery, Emory University School of Medicine, Atlanta, GA 30322

Transplantation tolerance, defined as allograft acceptance by an immunocompetent recipient in the absence of long-term immunosuppression, has remained an elusive goal in clinical transplantation. Robust experimental tolerance induction strategies have in common methods to induce mixed hemopoietic chimerism. To date, however, chimerism induction across allogeneic barriers has required recipient conditioning with irradiation or cytoablative agents. In this paper we show that B6 recipients of fully allogeneic BALB/c skin grafts treated with repeated doses of donor bone marrow and anti-CD40 ligand (CD40L) develop durable (>300 days), readily detectable (6–12%) multilineage hemopoietic chimerism, indefinite allograft acceptance (>300 days), and donor-specific tolerance to secondary skin grafts. Analysis of the TCR repertoire of treated mice indicates that the underlying mechanisms of tolerance are in part mediated by deletion of donor-reactive T cells. These data demonstrate that durable hemopoietic chimerism and robust transplantation tolerance can be achieved without cytotoxic conditioning using a potentially clinically applicable regimen.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. M. Miller, T. B. Thornley, T. Pearson, A. J. Kruger, M. Yamazaki, L. D. Shultz, R. M. Welsh, M. A. Brehm, A. A. Rossini, and D. L. Greiner
TLR Agonists Prevent the Establishment of Allogeneic Hematopoietic Chimerism in Mice Treated with Costimulation Blockade
J. Immunol., May 1, 2009; 182(9): 5547 - 5559.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Kurtz, F. Raval, C. Vallot, J. Der, and M. Sykes
CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance
Blood, April 9, 2009; 113(15): 3475 - 3484.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Xu, J. Yan, Y. Huang, P. M. Chilton, C. Ding, C. L. Schanie, L. Wang, and S. T. Ildstad
Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization
Blood, March 15, 2008; 111(6): 3266 - 3275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. H. Koehn, M. A. Williams, K. Borom, S. Gangappa, T. C. Pearson, R. Ahmed, and C. P. Larsen
Fully MHC-Disparate Mixed Hemopoietic Chimeras Show Specific Defects in the Control of Chronic Viral Infections
J. Immunol., August 15, 2007; 179(4): 2616 - 2626.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Westerhuis, W. G. E. Maas, R. Willemze, R. E. M. Toes, and W. E. Fibbe
Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance
Blood, September 15, 2005; 106(6): 2215 - 2220.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Domenig, A. Sanchez-Fueyo, J. Kurtz, S. P. Alexopoulos, C. Mariat, M. Sykes, T. B. Strom, and X. X. Zheng
Roles of Deletion and Regulation in Creating Mixed Chimerism and Allograft Tolerance Using a Nonlymphoablative Irradiation-Free Protocol
J. Immunol., July 1, 2005; 175(1): 51 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Metzler, P. Gfeller, M. Bigaud, J. Li, G. Wieczorek, C. Heusser, P. Lake, and A. Katopodis
Combinations of Anti-LFA-1, Everolimus, Anti-CD40 Ligand, and Allogeneic Bone Marrow Induce Central Transplantation Tolerance through Hemopoietic Chimerism, Including Protection from Chronic Heart Allograft Rejection
J. Immunol., December 1, 2004; 173(11): 7025 - 7036.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Waldmann and S. Cobbold
Exploiting Tolerance Processes in Transplantation
Science, July 9, 2004; 305(5681): 209 - 212.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Graca, A. Le Moine, C.-Y. Lin, P. J. Fairchild, S. P. Cobbold, and H. Waldmann
Donor-specific transplantation tolerance: The paradoxical behavior of CD4+CD25+ T cells
PNAS, July 6, 2004; 101(27): 10122 - 10126.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Boulday, J. Ashton-Chess, P. Bernard, G. Karam, H. Vie, A. Moreau, D. Minault, K. Lorre, J.-P. Soulillou, and G. Blancho
Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons
Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1752 - 1760.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Kurtz, J. Shaffer, A. Lie, N. Anosova, G. Benichou, and M. Sykes
Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells
Blood, June 1, 2004; 103(11): 4336 - 4343.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Ito, Y. Takeuchi, J. Shaffer, and M. Sykes
Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and nonirradiated sites
Blood, March 1, 2004; 103(5): 1949 - 1954.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. S. Kean, E. A. Manci, J. Perry, C. Balkan, S. Coley, D. Holtzclaw, A. B. Adams, C. P. Larsen, L. L. Hsu, and D. R. Archer
Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease
Blood, December 15, 2003; 102(13): 4582 - 4593.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. W. Soper, M. D. Lessard, C. D. Jude, A. J. T. Schuldt, R. M. Bunte, and J. E. Barker
Successful Allogeneic Neonatal Bone Marrow Transplantation Devoid of Myeloablation Requires Costimulatory Blockade
J. Immunol., September 15, 2003; 171(6): 3270 - 3277.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Blaha, S. Bigenzahn, Z. Koporc, M. Schmid, F. Langer, E. Selzer, H. Bergmeister, F. Wrba, J. Kurtz, C. Kiss, et al.
The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade
Blood, April 1, 2003; 101(7): 2886 - 2893.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Williams, A. B. Adams, M. B. Walsh, N. Shirasugi, T. M. Onami, T. C. Pearson, R. Ahmed, and C. P. Larsen
Primary and Secondary Immunocompetence in Mixed Allogeneic Chimeras
J. Immunol., March 1, 2003; 170(5): 2382 - 2389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Xu, S. P. Montgomery, E. H. Preston, D. K. Tadaki, D. A. Hale, D. M. Harlan, and A. D. Kirk
Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation
J. Immunol., March 1, 2003; 170(5): 2776 - 2782.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Yin, N. Dujovny, L. Ma, A. Varghese, J. Shen, D. K. Bishop, and A. S. Chong
IFN-{gamma} Production Is Specifically Regulated by IL-10 in Mice Made Tolerant with Anti-CD40 Ligand Antibody and Intact Active Bone
J. Immunol., January 15, 2003; 170(2): 853 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Williams, T. M. Onami, A. B. Adams, M. M. Durham, T. C. Pearson, R. Ahmed, and C. P. Larsen
Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen
J. Immunol., November 15, 2002; 169(10): 5387 - 5391.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. A. Taylor, C. J. Lees, J. M. Wilson, M. J. Ehrhardt, M. T. Campbell, R. J. Noelle, and B. R. Blazar
Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions
Blood, October 16, 2002; 100(9): 3400 - 3407.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. J. Brenner, T. H. Tung, J. N. Jensen, and S. E. Mackinnon
The Spectrum of Complications of Immunosuppression: Is the Time Right for Hand Transplantation?
J. Bone Joint Surg. Am., October 10, 2002; 84(10): 1861 - 1870.
[Full Text] [PDF]


Home page
J. Immunol.Home page
M. Eto, H. Hackstein, K. Kaneko, K. Nomoto, and A. W. Thomson
Promotion of Skin Graft Tolerance Across MHC Barriers by Mobilization of Dendritic Cells in Donor Hemopoietic Cell Infusions
J. Immunol., September 1, 2002; 169(5): 2390 - 2396.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Shirasugi, A. B. Adams, M. M. Durham, A. E. Lukacher, H. Xu, P. Rees, S. R. Cowan, M. A. Williams, T. C. Pearson, and C. P. Larsen
Prevention of Chronic Rejection in Murine Cardiac Allografts: A Comparison of Chimerism- and Nonchimerism-Inducing Costimulation Blockade-Based Tolerance Induction Regimens
J. Immunol., September 1, 2002; 169(5): 2677 - 2684.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Forman, R. M. Welsh, T. G. Markees, B. A. Woda, J. P. Mordes, A. A. Rossini, and D. L. Greiner
Viral Abrogation of Stem Cell Transplantation Tolerance Causes Graft Rejection and Host Death by Different Mechanisms
J. Immunol., June 15, 2002; 168(12): 6047 - 6056.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. S. Kean, M. M. Durham, A. B. Adams, L. L. Hsu, J. R. Perry, D. Dillehay, T. C. Pearson, E. K. Waller, C. P. Larsen, and D. R. Archer
A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation
Blood, March 1, 2002; 99(5): 1840 - 1849.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Yamada, A. D. Salama, and M. H. Sayegh
The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575.
[Full Text] [PDF]


Home page
J. Immunol.Home page
N. N. Iwakoshi, T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini4
Skin Allograft Maintenance in a New Synchimeric Model System of Tolerance
J. Immunol., December 1, 2001; 167(11): 6623 - 6630.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Williams, J. T. Tan, A. B. Adams, M. M. Durham, N. Shirasugi, J. K. Whitmire, L. E. Harrington, R. Ahmed, T. C. Pearson, and C. P. Larsen
Characterization of Virus-Mediated Inhibition of Mixed Chimerism and Allospecific Tolerance
J. Immunol., November 1, 2001; 167(9): 4987 - 4995.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. B. Adams, M. M. Durham, L. Kean, N. Shirasugi, J. Ha, M. A. Williams, P. A. Rees, M. C. Cheung, S. Mittelstaedt, A. W. Bingaman, et al.
Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplantation Tolerance, and Correct Genetic Hemoglobinopathies with Minimal Myelosuppression
J. Immunol., July 15, 2001; 167(2): 1103 - 1111.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. A. Taylor, C. J. Lees, H. Waldmann, R. J. Noelle, and B. R. Blazar
Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions
Blood, July 15, 2001; 98(2): 467 - 474.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. A. Taylor, R. J. Noelle, and B. R. Blazar
Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade
J. Exp. Med., June 4, 2001; 193(11): 1311 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Williams, J. Trambley, J. Ha, A. B. Adams, M. M. Durham, P. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen
Genetic Characterization of Strain Differences in the Ability to Mediate CD40/CD28-Independent Rejection of Skin Allografts
J. Immunol., December 15, 2000; 165(12): 6849 - 6857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Pugin, M.-C. Widmer, S. Kossodo, C.-M. Liang, H. L. Preas II, and A. F. Suffredini
Human Neutrophils Secrete Gelatinase B In Vitro and In Vivo in Response to Endotoxin and Proinflammatory Mediators
Am. J. Respir. Cell Mol. Biol., March 1, 1999; 20(3): 458 - 464.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.